This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
Journal: Journal of Electromagnetics, RF, and Microwaves in Medicine and Biology 2: 242-248 (2018)
Authors: S Fiocchi, E Chiaramello, L Luzi, A Ferrulli, M Bonato, Y Roth, A Zangen, P Ravazzani
Deep Transcranial Magnetic Stimulation (dTMS) is a neurostimulation technique for deep brain structures that has recently been successfully applied in the clinic for treatment of addiction.
In contrast to conventional magnetic stimulation, which uses planar coils (figure 8) to target specific superficial regions of the brain, dTMS requires the design of complex three-dimensional coils in order to induce deeply penetrating fields.
Recent clinical studies have focused on the use of H4 coils, which utilizes a left-right symmetric structure for bilateral stimulation of the prefrontal cortex and demonstrates efficacy for therapy such as smoking cessation. The mechanism of activity, however, remains poorly understood, in part because the affected regions of the brain are not known in detail.
In this work the authors quantified both electric field E distribution and its penetration depth in prefrontal cortex, induced by the H4 coil that was designed for the addiction treatment and by the traditional figure-8 coil for comparison.
The results show that H4 coil preferentially targets insula and cingulate cortex. Moreover, it can induce in the deepest tissues E amplitude ranging between the 20-40% of the cortical peak and it can penetrate the cortex up to 4 cm with E>50% of the cortical peak, thus noticeably increasing the penetration depth of the traditional TMS systems.
This study supports the use of H4 for targeting cortical and subcortical structures involved in addictive disorders.